Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer

Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)

(2017) Hitoshi Katai et al.   Gastric Cancer

Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence

(2017) Yuichiro Miki et al.   SURGICAL ONCOLOGY-OXFORD

Peritoneal dissemination in early gastric cancer: importance of the lymphatic route

(2016) Masao Yoshida et al.   VIRCHOWS ARCHIV

Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration

(2015) GUANZHAO LIANG et al.   Oncology Letters

The Global Burden of Cancer 2013

(2015) Christina Fitzmaurice et al.   JAMA Oncology

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma

(2012) Yin Li et al.   JOURNAL OF SURGICAL ONCOLOGY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY